Hemal Mehta, MBBS MD(Cantab.)

Hemal Mehta, MBBS MD(Cantab.)

www.drhemalmehta.com.au


Professional Affiliations

Academic Appointments
  • Associate Professor, University of Sydney, Sydney, NSW, Australia
Hospital Appointments
  • Strathfield Retina Clinic, Sydney, NSW, Australia
  • Sydney Retina Clinic, Sydney, NSW, Australia
  • Central Coast Eye Specialists, NSW, Australia

Education and Training

Retinal fellowship
Sydney Eye Hospital, Sydney, NSW, Australia
Retinal fellowship
Moorfields Eye Hospital, London, England, United Kingdom
Ophthalmology residency
London School of Ophthalmology , London, England, UK
Medical School
University College London , London, England, UK
Medical School
University of Cambridge , Cambridge, England, UK

Biography

Hemal Mehta is an academic ophthalmologist specialising in the management of macula diseases. He has expertise in retinal clinical trials, tracking real-world treatment outcomes and retinal imaging. Hemal is a retinal specialist on the Therapeutics Committee of the Royal Australian and New Zealand College of Ophthalmologists and is a medical retina Section Editor for the Journal Eye. He is an Associate Professor with Save Sight Registries, University of Sydney and on the Steering Committee of the Fight Retinal Blindness! (FRB!) project. He is an Honorary Consultant Ophthalmologist at Royal Free London NHS Foundation Trust and an advisor for the Royal College of Ophthalmologists of England national audit of age-related macular degeneration treatment outcomes. The clinical research during his previous fellowships at Sydney Eye Hospital and Moorfields Eye Hospital contributed to his MD research thesis (academically on par with a PhD) on ‘Novel endpoints in diabetic retinopathy clinical trials’ registered at Cambridge University. Hemal has over 60 peer-reviewed publications. He was recently awarded the Australian Vision Research RANZCO Primer Grant to support linking imaging with FRB! registry data. Hemal is Co-director of Clinical Trials Research at Strathfield Retina Clinic and has served as PI or Sub-PI in over 50 clinical trials.